SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,768,674	9,757,831	8,700,602	7,862,650	5,646,385	7,612,048
Market Cap Growth	-3.31%	12.15%	10.66%	39.25%	-25.82%	-42.48%
Enterprise Value	7,521,346	9,567,696	8,637,734	7,807,605	5,442,304	7,267,516
Last Close Price	99200.00	124600.00	111100.00	100400.00	72100.00	97200.00
PE Ratio	29.10	36.55	36.14	-	-	117.39
Forward PE	26.03	39.32	73.81	-	-	-
PS Ratio	10.99	13.81	15.89	22.16	22.94	18.18
PB Ratio	9.40	11.81	15.16	24.50	17.84	17.14
P/TBV Ratio	9.64	12.11	16.24	29.59	18.86	17.90
P/FCF Ratio	45.85	57.59	93.05	-	-	-
P/OCF Ratio	44.06	55.34	91.68	-	-	-
EV/Sales Ratio	10.64	13.54	15.77	22.00	22.11	17.36
EV/EBITDA Ratio	40.31	43.32	75.93	-	-	68.18
EV/EBIT Ratio	44.34	46.92	89.66	-	-	76.53
EV/FCF Ratio	44.39	56.47	92.38	-	-	-
Debt / Equity Ratio	0.06	0.06	0.32	0.56	0.49	0.04
Debt / EBITDA Ratio	0.22	0.22	1.62	-	-	0.15
Debt / FCF Ratio	0.29	0.29	1.97	-	-	-
Net Debt / Equity Ratio	-0.31	-0.31	-0.24	-0.20	-0.47	-0.72
Net Debt / EBITDA Ratio	-1.18	-1.18	-1.23	2.84	1.27	-2.99
Net Debt / FCF Ratio	-1.54	-1.54	-1.50	0.65	0.91	3.28
Asset Turnover	0.63	0.63	0.62	0.51	0.38	0.73
Inventory Turnover	0.41	0.41	0.40	0.35	0.53	0.60
Quick Ratio	1.83	1.83	1.26	1.47	2.28	2.64
Current Ratio	2.31	2.31	1.64	2.02	2.99	3.18
Return on Equity (ROE)	36.17%	36.17%	50.72%	-11.10%	-36.66%	15.75%
Return on Assets (ROA)	11.40%	11.40%	6.84%	-3.38%	-12.53%	10.38%
Return on Invested Capital (ROIC)	38.91%	40.80%	27.85%	-17.66%	-89.60%	127.86%
Return on Capital Employed (ROCE)	22.60%	22.60%	15.00%	-7.80%	-26.20%	19.20%
Earnings Yield	3.44%	2.74%	2.77%	-0.42%	-2.47%	0.85%
FCF Yield	2.18%	1.74%	1.07%	-1.23%	-2.92%	-1.28%
Buyback Yield / Dilution	-	-	-	-	-	-9.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.